E-LIB Suche - Ergebnisse für: Mallbris, Lotus

1

Lebrikizumab Provides Rapid Clinical Responses Across All E..:

Simpson, Eric L. ; de Bruin-Weller, Marjolein ; Hong, H. Chih-ho...
Dermatology and Therapy. 14 (2024) 5 - p. 1145-1160 , 2024

Link: https://doi.org/10.1007/..

2

Number Needed to Treat Network Meta-Analysis to Compare Bio..:

Leonardi, Craig L. ; See, Kyoungah ; Burge, Russel...
Advances in Therapy. 39 (2022) 5 - p. 2256-2269 , 2022

Link: https://doi.org/10.1007/..

3

Risk of respiratory infection in patients with plaque psori..:

Svedbom, Axel ; Mallbris, Lotus ; Ståhle, Mona
Journal of the American Academy of Dermatology. 85 (2021) 4 - p. 1013-1015 , 2021

Link: https://doi.org/10.1016/..

4

Psoriasis Severity Assessment Combining Physician and Patie..:

Leonardi, Craig ; See, Kyoungah ; Gallo, Gaia...
Dermatology and Therapy. 11 (2021) 4 - p. 1249-1263 , 2021

Link: https://doi.org/10.1007/..

5

Uniting Discovery and Care: The Role of Pharmaceutical Comp..:

Tan, Chenyun ; McGill, James M. ; Mallbris, Lotus
Journal of Investigative Dermatology. 140 (2020) 3 - p. 527-530 , 2020

Link: https://doi.org/10.1016/..

6

Ixekizumab—An Effective and Safe Treatment for Moderate-to-..:

Papp, Kim ; Blauvelt, Andrew ; Sullivan, John...
Journal of Psoriasis and Psoriatic Arthritis. 4 (2019) 4 - p. 180-185 , 2019

Link: https://doi.org/10.1177/..

7

A multi-item Physician Global Assessment scale to assess ps..:

Callis Duffin, Kristina ; Bushmakin, Andrew G. ; Cappelleri, Joseph C...
BMC Dermatology. 19 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

8

Duration of psoriatic arthritis as a risk factor for myocar..:

Egeberg, Alexander ; Skov, Lone ; Hansen, Peter Riis...
Rheumatology Advances in Practice. 2 (2018) 1 - p. , 2018

Link: https://doi.org/10.1093/..

9

Correction to: Efficacy and Safety of Switching to Ixekizum..:

Blauvelt, Andrew ; Papp, Kim A. ; Griffiths, Christopher E. M....
American Journal of Clinical Dermatology. 19 (2018) 3 - p. 457-457 , 2018

Link: https://doi.org/10.1007/..

10

The Physician Global Assessment and Body Surface Area compo..:

Walsh, Jessica A ; Jones, Heather ; Mallbris, Lotus...
Psoriasis: Targets and Therapy. 8 (2018) - p. 65-74 , 2018

Link: https://doi.org/10.2147/..

11

Ixekizumab treatment shows a neutral impact on cardiovascul..:

Egeberg, Alexander ; Wu, Jashin J. ; Korman, Neil...
Journal of the American Academy of Dermatology. 79 (2018) 1 - p. 104-109.e8 , 2018

Link: https://doi.org/10.1016/..

12

Maintenance of skin clearance with ixekizumab treatment of ..:

Leonardi, Craig ; Maari, Catherine ; Philipp, Sandra...
Journal of the American Academy of Dermatology. 79 (2018) 5 - p. 824-830.e2 , 2018

Link: https://doi.org/10.1016/..

13

Herpes zoster in psoriasis patients treated with tofacitini:

Winthrop, Kevin L. ; Lebwohl, Mark ; Cohen, Arnon D....
Journal of the American Academy of Dermatology. 77 (2017) 2 - p. 302-309 , 2017

Link: https://doi.org/10.1016/..

14

The relationship between duration of psoriasis, vascular in..:

Egeberg, Alexander ; Skov, Lone ; Joshi, Aditya A....
Journal of the American Academy of Dermatology. 77 (2017) 4 - p. 650-656.e3 , 2017

Link: https://doi.org/10.1016/..

15

Comment on "Quantitative Evaluation of Biologic Therapy Opt..:

Reich, Kristian ; Leonardi, Craig ; Papp, Kim...
Journal of Investigative Dermatology. 137 (2017) 12 - p. 2642-2644 , 2017

Link: https://doi.org/10.1016/..